Tekedia Capital has officially announced its investment in Exonic, a company specializing in unsupervised Biological AI. Exonic is recognized for its innovative approach to developing biological foundation models that effectively handle heterogeneous, unstructured, and noisy biological datasets. This investment aligns with Tekedia Capital's strategic focus on advancing business models that leverage cutting-edge technology in the life sciences sector. The decision reflects a commitment to supporting companies that are at the forefront of scientific innovation.
Related Articles
Don't miss out on breaking stories and in-depth articles.